More Good News for HIV PrEP Injectable

(MedPage Today) -- The long-acting HIV prevention medication cabotegravir led to an an estimated 66% lower HIV incidence versus oral tenofovir/emtricitabine (TDF/FTC), according to interim results from the HPTN 083 trial.
"The hazard ratio between...